Sudden cardiac death in patients with diabetes

Current Diabetes Reports

Volumn 4, Issue 3, 2004, Pages 187-193

  El Atat, Fadi A ^b   McFarlane, Samy I ^b   Sowers, James R ^b   Bigger, J Thomas ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTONOMIC NEUROPATHY; CARDIOMYOPATHY; CARDIOVASCULAR RISK; DIABETES MELLITUS; ECG ABNORMALITY; EPIDEMIC; HEART DEATH; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; PATHOGENESIS; PREVALENCE; REVIEW; SUDDEN DEATH;

EID: 3142550872     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-004-0022-8     Document Type: Review

References (71)

1. Center for Disease Control and Prevention: state-specific mortality from sudden cardiac death - United States, 1999 [no authors listed]. MMWR Morb Mortal Wkly Rep 2002, 51:123-126.
2. Kannel WB, Schatzkin A: Sudden death: lessons from subsets in population studies. J Am Coll Cardiol 1985, 5:141B-149B.
3. Jouven X, Desnos M, Guerot C, Ducimetiere P: Predicting sudden death in the population: the Paris Prospective Study I. Circulation 1999, 99:1978-1983.
4. Curb JD, Rodriguez BL, Burchfiel CM, et al.: Sudden death, impaired glucose tolerance, and diabetes in Japanese American men. Circulation 1995, 91:2591-2595.
5. Kannel WB, McGee DL: Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care 1979, 2:120-126.
6. Kannel WB, Wilson PW, D'Agostino RB, Cobb J: Sudden coronary death in women. Am Heart J 1998, 136:205-212.
7. Burke AP, Farb A, Malcom GT, et al.: Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation 1998, 97:2110-2116.
8. Ewing DJ, Boland O, Neilson JM, et al.: Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia 1991, 34:182-185.
9. Naas AA, Davidson NC, Thompson C, et al.: QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study. BMJ 1998, 316:745-746.
10. Elming H, Brendorp B, Kober L, et al.: QTc interval in the assessment of cardiac risk. Card Electrophysiol Rev 2002, 6:289-294.
11. Tong NW, Yang TG, Liang JZ: Ventricular late potentials in patients with diabetes mellitus. Zhonghua Nei Ke Za Zhi 1993, 32:464-466.
12. El-Atat F, McFarlane SI, Sowers JR: Diabetes, hypertension and cardiovascular derangements: pathophysiology and management. Curr Hypertens Rep 2004, 6:215-223.
13. Kannel WB, Thomas HE Jr: Sudden coronary death: the Framingham Study. Ann N Y Acad Sci 1982, 382:3-21.
14. Becker LB, Han BH, Meyer PM, et al.: The CPR Chicago Project. Racial differences in the incidence of cardiac arrest and subsequent survival. N Engl J Med 1993, 329:600-606.
15. Myerburg RJ, Kessler KM, Castellanos A: Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 1993, 119:1187-1197.
16. Sowers JR: Recommendations for special populations: diabetes mellitus and the metabolic syndrome. Am J Hypertens 2003, 16(11 suppl):41-45.
17. Schumacher MC, Smith KR: Diabetes in Utah among adults: interaction between diabetes and other risk factors for microvascular and macrovascular complications. Am J Public Health 1988, 78:1195-1201.
18. Butler WJ, Ostrander LD, Carman WJ, Lamphiear DE: Mortality from coronary heart disease in the Tecumseh Study: long-term effect of diabetes mellitus, glucose intolerance and other risk factors. Am J Epidemiol 1985, 121:541-547.
19. Morrish NJ, Stevens LK, Fuller JH, et al.: Incidence of macrovascular disease in diabetes mellitus: the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia 1991, 34:584-589.
20. Mihara T, Oohashi H, Hirata Y: Mortality of Japanese diabetics in a seven-year follow-up study. Diabetes Res Clin Pract 1986, 2:139-144.
21. Kannel WB, McGee DL: Epidemiology of sudden death: insights from the Framingham Study. In Sudden Cardiac Death. Edited by Josephson ME. Philadelphia, PA: FA Davis Co.; 1985:93-104.
22. Balkau B, Jouven X, Ducimetiere P, Eschwege E: Diabetes as a risk factor for sudden death. Lancet 1999, 354:1968-1969.
23. Wheeler SG, Ahroni JH, Boyko EJ: Prospective study of autonomic neuropathy as a predictor of mortality in patients with diabetes. Diabetes Res Clin Pract 2002, 58:131-138.
24. Rathman W, Ziegler D, Jahnke M, et al.: Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 1993, 10:820-824.
25. Ewing DJ, Campbell IW, Clarke BF: The natural history of diabetic autonomic neuropathy. Q J Med 1980, 49:95-108.
26. Valensi P,Huard JP,Giroux C,Attali JR:Factors involved in cardiac autonomic neuropathy in diabetic patients. J Diabetes Complications 1997,11:180-187.
27. Jouven X, Zureik M, Desnos M, et al.: Resting heart rate as a predictive risk factor for sudden death in middle-aged men. Cardiovasc Res 2001, 50:373-378.
28. Zipes DP, Levy MN, Cobb LA, et al.: Sudden cardiac death: neural-cardiac interactions. Circulation 1987, 76:1202-1207.
29. Dyer AR, Persky V, Stamler J et al.: Heart rate as a pronostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic study. Am J Epidemiol 1980, 112:736-749.
30. Kannel WB, Kannel C, Paffenbarger RS, et al.: Heart rate and cardiovascular mortality: the Framingham study. Am Heart J 1987, 113:1489-1494.
31. Shaper AG, Wannamethee G, McFarlane PW, et al.: Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men. Br Heart J 1993, 70:49-55.
32. Cook JR, Bigger JT, Kleiger RE, et al.: Effect of atenolol and diltiazem on heart rate variability in normal persons. J Am Coll Cardiol 1991, 17:480-484.
33. Orchard TJ, Lloyd CE, Maser RE, Kuller LH: Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Res Clin Pract 1996, 34(suppl):S165-S171.
34. La Rovere MT, Pinna GD, Hohnloser SH, et al.: Autonomic tone and reflexes after myocardial infarction. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation 2001, 103:2072-2077.
35. Whang W, Bigger JT Jr: Comparison of the prognostic value of RR-interval variability after acute myocardial infarction in patients with versus those without diabetes mellitus. Am J Cardiol 2003, 92:247-251.
36. Wirta O, Pasternack A, Mustonen J, Laippala P: Renal and cardiovascular predictors of 9-year total and sudden cardiac mortality in non-insulin-dependent diabetic subjects. Nephrol Dial Transplant 1997, 12:2612-2617.
37. Bigger JT Jr: Spectral analysis of R-R variability to evaluate autonomic physiology and pharmacology and to predict cardiovascular outcomes in humans. In Cardiac Electrophysiology from Cell to Bedside, edn 2. Edited by Zipes DP, Jalife J. Philadelphia, PA: WB Saunders; 1995:1151-1170.
38. Burke AP, Farb A, Malcom GT, et al.: Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997, 336:1276-1282.
39. Yano K, McCarthy LJ, Reed DM, Kagan A: Postmortem findings in sudden and non-sudden deaths among Japanese-American men in Hawaii. Am J Med 1987, 83:1037-1044.
40. Davies MJ, Thomas A: Thrombosis and acute coronary-artery lesions in sudden cardiac death. N Engl J Med 1984, 310:1137-1140.
41. Timmis AD: Diabetic heart disease: clinical considerations. Heart 2001, 85:463-469.
42. El-Atat F, Aneja A, Mcfarlane SI, Sowers JR: Obesity and hypertension. Endocrinol Metab Clin North Am 2003, 32:823-854.
43. Albert CM, Ruskin JN: Risk stratifiers for sudden cardiac death (SCD) in the community: primary prevention of SCD. Cardiovasc Res 2001, 50:186-196.
44. Albert CM, McGovern BA, Newell JB, Ruskin JN: Sex differences in cardiac arrest survivors. Circulation 1996, 93:1170-1176.
45. Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group [no authors listed]. JAMA 1982, 248:1465-1477.
46. Siscovick DS, Raghunathan TE, Psaty BM, et al.: Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994, 330:1852-1857.
47. Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group [no authors listed]. Am J Cardiol 1985, 55:1-15.
48. Friedlander Y, Siscovick DS, Weinmann S, et al.: Family history as a risk factor for primary cardiac arrest. Circulation 1998, 97:155-160.
49. Rozanski A, Blumenthal JA, Kaplan J: Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999, 99:2192-2217.
50. Januzzi JL, Stern TA, Pasternak RC, DeSanctis RW: The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med 2000, 160:1913-1921.
51. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT) [no authors listed]. Diabetologia 1998, 41:416-423.
52. McFarlane SI, Jacober SJ, Winer N, et al.: Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. Diabetes Care 2002, 25:718-723.
53. McFarlane SI, Shin JJ, Rundek T, Bigger JT: Prevention of type 2 diabetes. Curr Diabetes Rep 2003, 3:235-241.
54. Schwartz PJ, Randall WC, Anderson EA, et al.: Sudden cardiac death. Nonpharmacologic interventions. Circulation 1987, 76(1 Pt 2):1215-1219.
55. Wannamethee G, Shaper AG, Macfarlane PW, Walker M: Risk factors for sudden cardiac death in middle-aged British men. Circulation 1995, 91:1749-1756.
56. Albert CM, Mittleman MA, Chae CU, et al.: Triggering of sudden cardiac death by vigorous exertion. N Engl J Med 2000, 343:1351-1361.
57. Siscovick DS, Raghunathan TE, King I, et al.: Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995, 274:1363-1367.
58. Albert CM, Hennekens CH, O'Donnell CJ, et al.: Fish consumption and decreased risk of sudden cardiac death. JAMA 1998, 279:23-28.
59. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico [no authors listed]. Lancet 1999, 354:447-455.
60. Kang JX, Leaf A: Antiarrhythmic effects of polyunsaturated fatty acids: recent studies. Circulation 1996, 94:1774-1780.
61. Billman GE, Kang JX, Leaf A: Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation 1999, 99:2452-2457.
62. Kromhout D, Bosschieter EB, de Lezenne Coulander C: The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985, 312:1205-1209.
63. Norell SE, Ahlbom A, Feychting M, Pederson NL: Fish consumption and mortality from coronary heart disease. BMJ 1986, 293:426.
64. Fish consumption and mortality from coronary heart disease [no authors listed]. N Engl J Med 1985, 313:820-824.
65. Daviglus ML, Stamler J, Orencia AJ, et al.: Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997, 333:1046-1053.
66. Albert CM, Manson JE, Cook NR, et al.: Moderate alcohol consumption and the risk of sudden cardiac death among US male physicians. Circulation 1999, 100:944-950.
67. Wannamethee G, Shaper AG: Alcohol and sudden cardiac death. Br Heart J 1992, 68:443-448.
68. Yusuf S, Peto R, Lewis J, et al.: Beta blockade during and after myocardial infarction an overview of the randomized trials. Prog Cardiovasc Dis 1985, 27:335-371.
69. Kontopoulos AG, Athyros VG, Papageorgiou AA, et al.: Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients. Coron Artery Dis 1997, 8:517-524.
70. Binkley PF, Haas GJ, Starling RC, et al.: Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol 1993, 21:655-661.
71. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators [no authors listed]. Lancet 1993, 342:821-828.